Exclusive: drug manufacturers to raise prices for 2021, as political pressure pandemics jeopardize revenue
Exclusive: drug manufacturers to raise prices for 2021, as political pressure pandemics jeopardize revenue
British health service lowers delivery interval of second Pfizer coronavirus vaccine to expensive company not tested
The best fund manager of 2020 warns more than half of the S&P 500 runs the risk of technological revolution